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Letters to the Editor 235zone in late reperfused myocardial infarction (3), which is
unlikely to be related to actual salvage but more likely reflects an
inflammatory response of adjacent tissue, is possibly related to
reperfusion injury. Moreover, in several studies, the area at risk
was consistently larger in the group with more severe injury as
indicated by myocardial hemorrhage (5).
Because the histologic assessment of myocardial edema is challeng-
ing and virtually impossible in clinical models, experimental and
clinical research will have to use CMR and careful study designs to
scrutinize the impact of reperfusion and other, less important potential
confounders on the extent of myocardial edema.
Despite these knowledge gaps, there is solid evidence that
T2-weighted imaging is closely correlated with the area at risk in
reperfused MI and, in combination with late Gd enhancement
imaging, allows for the assessment of myocardial salvage. Before
having a more clear understanding of confounders, it may be too
early to claim a precision in the 10% range. Clearly, further
studies are required to understand the impact of potential
clinical confounders, yet there is little doubt that the available
techniques provide unique invaluable in vivo data on myocardial
injury in patients with reperfused MI.
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REPLY
We thank Dr. Mewton and colleagues for adding to the
discussion regarding T2-weighted cardiac magnetic resonance
(CMR). Often, a candid debate will invoke strong reactions, but
we are hopeful that readers of our Pro/Con article (1) with Dr.
Friedrich will carefully consider the merits of the respective
arguments. Here, we present our perspective on the issues raised
by Dr. Mewton and colleagues.
At the outset, philosophically, we take exception to the comment
that: “As always, in such a debate truth probably relies somewhere in
between.” At issue is whether or not T2-weighted CMR depictspost-infarct myocardium at risk. Fundamentally, it can only be one
or the other.
With regard to the other issues raised:
1. We agree that T2-CMR can show myocardial edema—which
we believe is a marker of necrosis in the setting of acute ischemic
injury.
2. We agree that T2-CMR can provide incremental data to
delayed-enhancement imaging.
3. We agree that T2-short tau inversion recovery (as well as
double-inversion T2-turbospin echo) is sensitive to many artifacts.
These artifacts may be indistinguishable from true abnormalities
and/or render images non diagnostic. As such, we believe that
“classic,” black-blood T2-CMR is often neither convenient nor
simple.
4. We strongly disagree that myocardial edema correlates with
the myocardial area at risk (AAR). As we note in our paper, (1) the
fundamental problem is that the underlying physiology is incom-
patible with this hypothesis. With respect to water content (and
many other physiological parameters), it is well-known that the
post-infarct AAR is markedly heterogeneous, with the infarcted
portion having 10-fold or more edema than the salvaged, viable
portion. While newer pulse sequences may improve image quality,
these methods will not overcome this fundamental issue.
5. We agree that from a pathophysiological perspective, assum-
ing that there is a direct linear relationship between the AAR
(simply the perfusion territory of an epicardial coronary artery) and
myocardial edema is highly problematic. T2-CMR does not index
perfusion, but instead reflects dynamic and complex changes
occurring within infarcted myocardium, including inflammation,
hemorrhage, and microvascular obstruction, among others.
6. We are puzzled regarding the comment on interstitial edema.
Because the literature is quite clear that total water content is not
appreciably elevated within salvaged myocardium, it is unclear how
interstitial or any other form of edema can provide a mechanism for
the depiction of the AAR.
7. We disagree that delayed-enhancement CMR overestimates
infarct size in the acute setting. A definitive validation study (2)
should take precedence over reports—even if several—in which the
“evidence” is simply size differences measured on CMR datasets,
often with variable image quality.
8. Finally, with regard to the possibility that the combination of
“early” and conventional “late” gadolinium-enhanced CMR can
depict salvaged myocardium (3), we are disheartened by the line of
reasoning that afflicts this and the majority of T2-CMR reports—
namely that size differences between 2 CMR depictions of the
“abnormal” zone must represent a pathophysiology. Presumably,
most practitioners would not assume that the consistent overesti-
mation of left ventricular mass as measured by gradient-echo
cine-CMR as compared with steady-state free precession cine-
CMR reflects a new pathophysiology.
The physiological basis for interpreting “early” delayed enhance-
ment or T2-CMRhyperintensity as the area-at-risk is poorly described
and/or inconsistent with known precepts. We are left to conclude that
with new imaging techniques, it is paramount that definitive
pathology-based validation studies be performed. If appropriate vali-
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Letters to the Editor236dation data is absent, the focus should be on how the underlying
physiology informs cardiac imaging and not the other way around.
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